ALZ Discovery
131 FOLLOWERS
Founded in 1998 by co-chairmen Leonard A. and Ronald S. Lauder, the Alzheimer's Drug Discovery Foundation (ADDF) is the only charity solely focused on finding drugs for Alzheimer's. The mission of the Alzheimer's Drug Discovery Foundation is to rapidly accelerate the discovery of drugs to prevent, treat and cure Alzheimer's disease. Learn more about Alzheimer, our research,..
ALZ Discovery
1y ago
Alzheimer’s Drug Discovery Foundation Funds Second Phase of Global Alzheimer’s Prevention FINGER TRIAL ..read more
ALZ Discovery
1y ago
This year tested us like no other, but from great challenges came innovation and creativity as we drove forward our mission to identify new therapies to prevent and treat Alzheimer’s disease ..read more
ALZ Discovery
1y ago
The FDA made a landmark decision on June 7, approving aducanumab (Aduhelm™, Biogen) for the treatment of Alzheimer’s disease. Aducanumab is the first new Alzheimer’s treatment in 17 years and the first ever shown to modify the course of the disease ..read more
ALZ Discovery
1y ago
The ADDF scientific affairs team and I recently participated in the 13th Clinical Trials on Alzheimer’s Disease (CTAD) conference ..read more
ALZ Discovery
1y ago
I sat down with two outstanding ADDF-funded researchers recently to talk about the latest news on their cutting-edge work, the inspiration for their ideas, and when we can expect results from their latest trials.  ..read more
ALZ Discovery
1y ago
Robust Alzheimer’s Clinical Trial Portfolio Provides More Opportunities for Patient Participation ..read more
ALZ Discovery
1y ago
Earlier this year, two outstanding researchers, Paul Fish, Ph.D., and Paul Worley, M.D., were selected by the ADDF and Harrington Discovery Institute to receive ADDF-Harrington Scholar Awards ..read more
ALZ Discovery
1y ago
The FDA approved aducanumab (Aduhelm®), an antibody that clears amyloid plaques from the brain, in June.  ..read more